Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Antibody 246

Antibody Vaccination Vaccine Dermatology 246

XTalks

OCTOBER 26, 2023

The best way to prevent the flu is by getting vaccinated every year. The CDC and the World Health Organization (WHO) recommend annual flu vaccination for most people, especially those at high risk of serious complications, like pregnant women, elderly individuals, children and people with certain chronic health conditions.

Vaccination 105

Vaccination Vaccine RNA Manufacturing 105

XTalks

MARCH 23, 2022

The ad highlights Exact Sciences’ Cologuard, a DNA-based stool test for colon cancer detection. The editorial team also learned about Alnylam Pharmaceuticals’ lawsuits against mRNA COVID-19 vaccine makers Pfizer and Moderna over patent infringements. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science RNA Vaccination Vaccine 52

Pharmaceutical Technology

MAY 15, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Life Science 162

Life Science DNA Antibody Development 162

pharmaphorum

AUGUST 27, 2020

The Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), works with universities, research organisations, businesses, charities, and government to develop a supportive ecosystem. The first is that the development of vaccines is utilising cutting edge technologies.

Vaccination 122

Vaccination Vaccine Life Science Clinical Trials 122

Pharmaceutical Technology

NOVEMBER 22, 2022

Vaccines are our number one weapon in the fight against infectious diseases, but their development has historically involved a long and complex process taking up to a decade. Before COVID-19, Merck held the record for the fastest modern vaccine ever developed. mRNA’s potential for rapid vaccine delivery.

Manufacturing 130

Manufacturing Vaccination Vaccine RNA 130

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.

Genome 244

Genome Genomics Medicine Gene Therapy 244

pharmaphorum

JANUARY 30, 2022

2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top life science hubs and apparently shrugging off the effects of the pandemic and Brexit. “History has handed the UK two world-leading sectors: life sciences and finance.

Life Science 98

Life Science Allergies DNA Licensing 98

XTalks

FEBRUARY 11, 2021

Amidst growing global shortages of COVID-19 vaccine supplies, inaugural (by way of authorizations/approvals) COVID-19 vaccine maker Pfizer is addressing the issue by working to cut the manufacturing time of its vaccine by almost half. Related: Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production.

Manufacturing 52

Manufacturing Vaccination Vaccine DNA 52

The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” . PLYMOUTH MEETING, Pa. , PLYMOUTH MEETING, Pa. ,

DNA 40

DNA Vaccine Vaccination Immune Response 40

pharmaphorum

FEBRUARY 3, 2021

The data show that 2020 was a “watershed year” for UK biotech , according to BIA chief executive Steve Bates, who said the uplift was seen across the life sciences category, not just organisations that were directly involved in the COVID-19 response.

Life Science 111

Life Science DNA Development Vaccination 111

Pharmaceutical Technology

APRIL 18, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. These can serve as an important component of a vaccine.

Protein 147

Protein Vaccination Vaccine Production 147

XTalks

MARCH 1, 2024

International HPV Awareness Day 2024 is an essential call to action for increased education, vaccination uptake and access to screening and treatment services. In addition, some types of HPV vaccines can be given to those older than 26 years of age.

Vaccination 52

Vaccination Vaccine Life Science FDA Approval 52

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Antibody 147

Antibody Vaccination Vaccine Dermatology 147

XTalks

DECEMBER 13, 2023

Related: Top 30 Pharma Companies in 2023: Statistics and Trends 1) Moderna Compound annual growth rate: 415 percent Moderna, headquartered in Massachusetts, is a prominent biotechnology company specializing in RNA therapeutics, particularly mRNA vaccines. vaccine, mRNA-1273.815.

Genetics 111

Genetics Vaccination Vaccine DNA 111

XTalks

FEBRUARY 12, 2024

In the commercial, Pfizer highlighted some of its major scientific offerings throughout the centuries, which include contributions to the mass production of penicillin and creating COVID-19 vaccines. In 2023, alone, the company said its medicines and vaccines reached more than 1.3

Scientist 105

Scientist DNA Vaccination Vaccine 105

Delveinsight

JULY 29, 2020

Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus. Several pharma and biotech companies are developing and manufacturing safe and effective vaccines to fight coronavirus. India’s COVID-19 vaccine candidates.

Vaccination 62

Vaccination Vaccine Clinical Trials Clinical Trials 62

Pharmaceutical Technology

MAY 8, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Genetics 130

Genetics DNA Genetic Engineering Antibody 130

XTalks

NOVEMBER 30, 2023

The noteworthy candidate, EBT-101, is designed to eliminate HIV proviral DNA using CRISPR-Cas9 along with two guide RNAs (gRNAs). These dual gRNAs target three specific sites within the HIV genome, facilitating the removal of substantial portions of the viral DNA and minimizing the potential for viral escape.

FDA Approval 111

FDA Approval Gene Therapy Gene Clinical Trials 111

Pharmaceutical Technology

APRIL 18, 2023

Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely.

Drugs 130

Drugs Antibody Life Science DNA 130

pharmaphorum

AUGUST 31, 2022

It seems the FDA is trying to get ahead of any scepticism about gene therapies that proved complicated when encouraging uptake of COVID-19 vaccines. The technology operates through mobile genetic elements (MGEs), which are segments of DNA that code enzymes and proteins to move DNA within the genome. A broadening pipeline.

Gene Therapy 98

Gene Therapy Gene Gene Editing DNA 98

XTalks

JUNE 20, 2022

XTALKS WEBINAR: Liquid Biopsy Workflow Optimization for Improved Assay Sensitivity and Multianalyte Applications of Cell-Free RNA, DNA and CTCs. The featured speaker will discuss the need of standardized workflows as well as the need for blood stabilization for circulating cell-free DNA (ccfDNA) analysis and impact on assay sensitivity.

FDA Approval 98

FDA Approval Protein Genetics RNA 98

pharmaphorum

OCTOBER 12, 2022

The payload, Del Bourgo tell us, is the therapeutic DNA or RNA sequence that will cure or fix damaged cells. Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. “This is just the beginning; the potential is enormous,” he says.

Genome 105

Genome Genomics Medicine Development 105

XTalks

MARCH 31, 2021

A new report from the Center for Countering Digital Hate (CCDH) and Anti-Vax Watch has identified 12 individuals, dubbed the “Disinformation Dozen,” as being responsible for spreading up to 65 percent of all online anti-vaccine information. The Disinformation Dozen includes influential anti-vax leaders such as Robert F. Kennedy Jr.,

Vaccination 75

Vaccination Vaccine DNA Doctor 75

The Pharma Data

JANUARY 5, 2021

This will empower public and private entities to react quickly to any potential changes in pathogenicity of the virus or effectiveness of diagnostics, therapeutics, and vaccines. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. About Illumina.

Genomics 52

Genomics Genome Life Science Development 52

XTalks

SEPTEMBER 30, 2020

The team sequenced DNA from 659 critically ill COVID-19 patients and 534 controls with mild or asymptomatic disease. People with the autoantibodies could be advised to take extra precautionary measures against exposure to COVID-19, or be prioritized for vaccination, said Zuniga. The analysis revealed that 23 (3.5

Antibody 135

Antibody Genetics Research In-Vitro 135

XTalks

AUGUST 2, 2023

In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

MARCH 10, 2021

Along with COVID-19 vaccine authorizations, the US Food and Drug Administration (FDA) remains committed to increasing access to COVID-19 tests and supporting their development, having authorized three new tests recently for emergency use. The products encompass molecular, antigen and T cell-based testing approaches.

Protein 98

Protein RNA Antibody Production 98

XTalks

OCTOBER 8, 2024

A gene contains instructions within our DNA. Once in the shadows of DNA, interest in RNA has been increasing within both scientific and public circles. Hungarian scientist Katalin Kariko and US colleague Drew Weissman shared the 2023 prize for developing mRNA technology that led to the mRNA COVID-19 vaccines.

Regulation 52

Regulation Genetics Scientist RNA 52

XTalks

AUGUST 12, 2020

Xtalks spoke to lead author on the study, Mohamed Abdel-Mohsen, PhD, assistant professor, Vaccine & Immunotherapy Center at the Wistar Institute, about the emerging utility of identifying glycomic, or sugar, signatures on the surface of immune cells to help in their identification and potential targeting.

RNA 52

RNA Protein DNA In-Vivo 52

Delveinsight

SEPTEMBER 2, 2021

In this case, Delfi is developing a highly sensitive and specific assay intended for comprehensive and cost-effective distribution and adoption by utilizing an advanced machine learning algorithm to the circulating DNA fragment patterns, which can be evaluated through low-cost sequencing.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72

XTalks

DECEMBER 24, 2020

The pandemic propelled the life science and healthcare sectors onto center stage, and they rose to the occasion against the most unprecedented health challenge in recent times. For example, investment in mRNA vaccines and viral vectors came well before January, many years before it. Here is a review of what 2020 served up.

Life Science 111

Life Science Vaccination Vaccine Gene 111

XTalks

MAY 17, 2024

Every year on May 18th, the global community commemorates World AIDS Vaccine Day, also known as HIV Vaccine Awareness Day. Led by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID), World AIDS Vaccine Day emphasizes the importance of awareness and education in the fight against HIV/AIDS.

Vaccination 52

Vaccination Vaccine Research Immune Response 52

Pharmaceutical Technology

MARCH 29, 2023

On March 28, the UK government announced that four UK life sciences companies will receive £277 million to help fund and advance manufacturing projects in medical diagnostics and human medicines. This is the first big spend being made from the UK’s Life Sciences Innovative Manufacturing Fund (LSIMF).

Life Science 276

Life Science Manufacturing Gene Therapy Medicine 276

XTalks

FEBRUARY 26, 2021

Having become a staple in research labs, HeLa cells have been in use for over 60 years, having been used in the development of the first live polio vaccine, drugs for treating herpes, Parkinson’s and leukemia, as well as in AIDS research and determining the long-term effects of radiation.

Scientist 69

Scientist Research Genetics Cosmetics 69

Pharmaceutical Technology

MAY 26, 2023

Enzymatic DNA production company Touchlight have augmented its DNA production capabilities with a newly announced expansion to its London facilities. Tripling its production capacity, Touchlight can now manufacture 8kg plasmid DNA, a key component for mRNA gene therapies and vaccines.

DNA 130

DNA Manufacturing Gene Gene Therapy 130

XTalks

FEBRUARY 3, 2021

Vaccine candidates from Novavax and Johnson & Johnson are looking to join the growing list of authorized COVID-19 vaccines as the companies recently posted positive efficacy data from large-scale Phase III trials evaluating their respective vaccines. Related: Moderna’s COVID-19 Vaccine Effective Against New Variants.

Vaccination 103

Vaccination Vaccine Trials Protein 103